Oxford Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Oxford Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,947	Closed	-$28K	–	2024
2019 Q1	$28K	Sell	19,947 -119,876	-86%	-$168K	﹤0.01%	1611
2018 Q4	$168K	Sell	139,823 -134,810	-49%	-$261K	﹤0.01%	1578
2018 Q3	$649K	Sell	274,633 -145,821	-35%	-$363K	0.01%	1199
2018 Q2	$1.11M	Sell	420,454 -180,657	-30%	-$498K	0.02%	984
2018 Q1	$1.65M	Sell	601,111 -61,398	-9%	-$178K	0.03%	684
2017 Q4	$2.08M	Buy	662,509 +440,435	+198%	+$1.24M	0.04%	550
2017 Q3	$635K	Sell	222,074 -85,664	-28%	-$231K	0.01%	1122
2017 Q2	$788K	Sell	307,738 -57,163	-16%	-$156K	0.02%	962
2017 Q1	$1.34M	Buy	364,901 +325,540	+827%	+$1.38M	0.03%	698
2016 Q4	$190K	Buy	+39,361	New	+$1.17M	0.01%	704
2016 Q3	–	Sell	-5,239	Closed	-$267K	–	885
2016 Q2	$267K	Buy	+5,239	New	+$260K	0.01%	662

Other funds holding ISEE

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Oxford Asset Management's ISEE Position: Q2 2019 in Review

Oxford Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2019, closing a stake of 19,947 shares — an estimated $28K sold.

Oxford Asset Management first reported a position in ISEE in Q2 2016 and held it in 11 quarters. The position peaked at $2.08M in Q4 2017. 52 funds tracked by Wall St. Rank hold ISEE as of Q2 2019.

Oxford Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Oxford Asset Management sold 19,947 IVERIC bio, Inc. Common Stock shares in Q2 2019, an estimated $28K.
Oxford Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 11 quarters.
Oxford Asset Management's IVERIC bio, Inc. Common Stock position peaked at $2.08M in Q4 2017.
52 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.